Figure 8From: The development and validation of an LC-MS/MS method for the determination of a new anti-malarial compound (TK900D) in human whole blood and its application to pharmacokinetic studies in mice Mean blood concentration vs . time profiles of TK900E following the administration of (A) 40 and 20 mg/kg TK900E orally and (B) 5 and 2.5 mg/kg TK900E intravenously to healthy male C57BL/6 mice (n = 5). Back to article page